Nuvectis Pharma, Inc. NVCT Increase Decrease In Accrued Compensation And Benefits
Increase Decrease In Accrued Compensation And Benefits at other companies
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept nvct:IncreaseDecreaseInAccruedCompensationAndBenefits.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s increase decrease in accrued compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s increase decrease in accrued compensation and benefits?
- Nuvectis Pharma, Inc. (NVCT) reported increase decrease in accrued compensation and benefits of -$460K in Q1 2026.
- How has Nuvectis Pharma, Inc.'s increase decrease in accrued compensation and benefits changed year-over-year?
- Nuvectis Pharma, Inc.'s increase decrease in accrued compensation and benefits increased by 11.4% year-over-year, from -$519K to -$460K.
- What does increase decrease in accrued compensation and benefits mean?
- This metric represents the net change in liabilities related to employee compensation, bonuses, and benefits that have been earned but not yet paid out by the company. It reflects the timing difference between the recognition of personnel-related expenses and the actual cash disbursement. A positive change indicates an increase in unpaid compensation obligations, effectively serving as a source of operating cash flow, while a negative change reflects the settlement of these liabilities.